(Q34793040)

4 August 2017

1 reference

title

Cryptosporidiosis: biology, pathogenesis and disease (English)

1 reference

4 August 2017

0 references

1 reference

1

Saul Tzipori

1 reference

4 August 2017

2

Honorine Ward

1 reference

4 August 2017

1 August 2002

1 reference

4 August 2017

Microbes and Infection

1 reference

4 August 2017

4

1 reference

4 August 2017

1047-1058

1 reference

4 August 2017

10

1 reference

Cryptosporidium and cryptosporidiosis in man and animals.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Natural history and biology of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Hepatic intranuclear particles in patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Genetic heterogeneity and PCR detection of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Patent gut infections in immunosuppressed adult C57BL/6N mice following intraperitoneal injection of Cryptosporidium parvum oocysts

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Eimeria spp. of domestic fowl: the migration of sporozoites intra- and extra-enterically

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

The extraintestinal stages of Eimeria tenella and E. maxima in the chicken

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Innate and cell-mediated immune responses to Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidium: molecular basis of host-parasite interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Mix and match modules: structure and function of microneme proteins in apicomplexan parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Characterization of a major sporozoite surface glycoprotein of Cryptosporidum parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

The immunodominant 17-kDa antigen from Cryptosporidium parvum is glycosylphosphatidylinositol-anchored

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Expression of the highly polymorphic Cryptosporidium parvum Cpgp40/15 gene in genotype I and II isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Virulence of three distinct Cryptosporidium parvum isolates for healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Unusual cryptosporidium species recovered from human faeces: first description of Cryptosporidium felis and Cryptosporidium 'dog type' from patients in England

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidium canis n. sp. from domestic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidium infection and CD4 counts

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Respiratory cryptosporidiosis in the acquired immune deficiency syndrome. Use of modified cold Kinyoun and Hemacolor stains for rapid diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidium as cause of laryngotracheitis in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Symptoms and transmission of intestinal cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Cryptosporidiosis: laboratory investigations and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Antibody-based immunotherapy of cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Combination drug therapy for cryptosporidiosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2802%2901629-5

7 January 2021

10.1016/S1286-4579(02)01629-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12191655